It is a broadly described annual report of Orion Pharma Limited in the year of 2014. During the financial year, The Company’s Total Revenue from sales BDT 2,449,956,082 million. Cost of Goods Sold BDT 1,088,516,230 million. Interest and Others Income BDT 46,857,510 million. Provision for income tax BDT 68,976,332 million.
The Board of Directors has recommended @15% cash dividend for the period ended 30th June 2016 for the Shareholders of the company. These financial statements are presented in Bangladesh Taka (Taka/Tk/BDT) which is the company’s functional currency. All financial information presented in Taka has been rounded off to the nearest Taka.
More Annual Report of Orion Pharma Limited:
